Back

Title
  • Trend for Clinical Use of Metabolic Associated Fatty Liver Disease (MAFLD)
Creator
    • Bando, Hiroshi
Rights
  • This is an open-access article distributed under the Creative Commons Attribution License(https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.
Subject
  • Other Fatty Liver
  • Other Non-Alcoholic Fatty Liver Disease
  • Other Metabolic Associated Fatty Liver Disease
  • Other Non-Alcoholic Steatohepatitis
Description
  • Other The problems among obesity, diabetes mellitus (DM), fatty liver, metabolic dysfunction have been prevalent, and diagnostic criteria as non-alcoholic fatty liver disease (NAFLD) has been used in practice. When diagnosing NAFLD, to exclude other related liver diseases was necessary, including excessive alcohol intake. The international experts proposed the proper term from NAFLD to metabolic associated fatty liver disease (MAFLD). MAFLD criteria include the evidence of the presence of hepatic steatosis associated with three situations. They are obesity/overweight, presence of Type 2 DM (T2DM), or metabolic impaired function, which were studied in the light of pathophysiology, epidemiology, diagnosis and pharmacotherapy.
Publisher Asploro
Date
    Issued2021-04-30
Language
  • eng
Resource Type journal article
Version Type VoR
Identifier URI http://repo.lib.tokushima-u.ac.jp/115958
Relation
  • isIdenticalTo DOI https://doi.org/10.36502/2021/ASJBCCR.6237
Journal
    • ISSN 2582-0370
      • Asploro Journal of Biomedical and Clinical Case Reports
      • Volume Number4 Issue Number2 Page Start99 Page End102
File
Oaidate 2023-06-26